Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 21.32 mg (equivalent: lidocaine hydrochloride, qty 20 mg) - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - lidocaine noridem solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia, peripheral nerve block, epidural block, subarachnoid block.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 42.64 mg (equivalent: lidocaine hydrochloride, qty 40 mg) - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide - lidocaine noridem solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia, peripheral nerve block, epidural block, subarachnoid block.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 53.3 mg (equivalent: lidocaine hydrochloride, qty 50 mg) - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium hydroxide - lidocaine noridem solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia, peripheral nerve block, epidural block, subarachnoid block.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 213.2 mg (equivalent: lidocaine hydrochloride, qty 200 mg) - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide - lidocaine noridem solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia, peripheral nerve block, epidural block, subarachnoid block.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 106.6 mg (equivalent: lidocaine hydrochloride, qty 100 mg) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; sodium chloride - lidocaine noridem solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia, peripheral nerve block, epidural block, subarachnoid block.

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - bupivacaine hydrochloride - solution for injection - 5.0 mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - midazolam 5 mg/ml (present as midazolam hydrochloride 5.5556mg/ml);   - solution for injection - 5 mg/ml - active: midazolam 5 mg/ml (present as midazolam hydrochloride 5.5556mg/ml)   excipient: hydrochloric acid sodium chloride sodium hydroxide as 1n solution, for ph adjustment, ph 3.3±0.1 water for injection - hypnovel is indicated for adults · premedication before induction of anaesthesia · conscious sedation before diagnostic or surgical interventions carried out under local anaesthesia · long-term sedation in intensive care units · induction and maintenance of anaesthesia. as an induction agent in inhalation anaesthesia or a sleep-inducing component in combined anaesthesia, including total intravenous anaesthesia. children · premedication before induction of anaesthesia · conscious sedation before diagnosticc or surgical interventions carried out under local anaesthesia · ataralgesia in combination with ketamine · ataralgesia in combination with ketamine in children (i.m. administration).

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - midazolam 5 mg/ml;   - solution for injection - 5 mg/ml - active: midazolam 5 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - conscious sedation before diagnostic or surgical interventions carried out under local anaesthesia (intravenous administration), or in children intranasal or oral administration. long-term sedation in intensive care units (intravenous administration as bolus injection or continuous infusion).

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - ranitidine - solution for injection/infusion - 25 milligram(s)/millilitre - h2-receptor antagonists; ranitidine

Malta - English - Medicines Authority

wockhardt uk limited - levomepromazine hydrochloride - solution for injection - levomepromazine hydrochloride 25 mg/ml - psycholeptics